Cough Peak Flow for Extubation Prediction
Launched by HOSPICES CIVILS DE LYON · Jul 25, 2016
Trial Information
Current as of May 16, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18 years
- • Intubation \> 24h
- • Eligible for scheduled weaning trial and then scheduled extubation
- • Mechanical ventilation from Evita XL ventilator (Dräger, Germany)
- • Patient's agreement to participate
- Exclusion Criteria:
- • - Withdrawal decision of life supporting care
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lyon, , France
Patients applied
Trial Officials
Florent GOBERT, MD
Principal Investigator
Hospices Civils de Lyon
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials